MDL | MFCD30533663 |
---|---|
Molecular Weight | 333.38 |
Molecular Formula | C11H15N3O5S2 |
SMILES | O=C(NC(N)=N)C1=CC(S(=O)(C)=O)=C(S(=O)(C)=O)C=C1C |
Rimeporide (EMD-87580) is a potent and selective inhibitor of the Na + /H + exchanger (NHE-1).
NHE1 [1]
Blocking NHE-1 activity has been shown to decrease intracellular Na + and Ca 2+ overload and pH and Rimeporide (EMD-87580) represents a new therapeutic option for duchenne muscular dystrophy (DMD). Rimeporide (EMD-87580) is expected to act as a muscle-sparing agent and its mode of action means that it is mutation independent [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
NCT Number | Sponsor | Condition | Start Date | Phase |
---|---|---|---|---|
NCT02710591 | EspeRare Foundation |
Muscular Dystrophy, Duchenne
|
March 2016 | Phase 1 |
Solid
Room temperature in continental US; may vary elsewhere.
Powder | -20°C | 3 years |
---|---|---|
In solvent | -80°C | 6 months |
-20°C | 1 month |
DMSO : 20 mg/mL ( 59.99 mM ; Need ultrasonic and warming)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 2.9996 mL | 14.9979 mL | 29.9958 mL |
5 mM | 0.5999 mL | 2.9996 mL | 5.9992 mL |
10 mM | 0.3000 mL | 1.4998 mL | 2.9996 mL |